ReviewSeminars in hearing2025
Hearing Aid Adoption in the OTC Hearing Aid Era: Market Trends and Consumer Insights from MarkeTrak 2025.
Review in Seminars in hearing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Preserving music reward in age-related hearing loss through training and adaptation.BMC geriatrics · 2026Article
- Self-Reported Treatment for Hearing Loss in Adults Living With or Without Human Immunodeficiency Virus (HIV).Cureus · 2026Article
- Exploring the Effects of Attribute Framing and Popularity Cueing on Hearing Aid Purchase Likelihood.Audiology research · 2026Article
- Over-the-counter hearing aids and integrated health-monitoring sensors: a review of clinical evidence and implementation.Frontiers in digital health · 2026Review
- Tracking Change: What MarkeTrak and EuroTrak Reveal About Global Hearing Aid Trends.Seminars in hearing · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2025 iteration of the MarkeTrak survey offers a comprehensive analysis of hearing aid adoption trends in the United States, with a particular focus on the impact of over-the-counter (OTC) hearing aids introduced in 2022. This study explores evolving consumer behaviors, demographic shifts, and clinical and psychosocial factors influencing hearing aid uptake. Findings reveal a continued increase in overall adoption rates, with OTC devices serving as a critical access point for first-time users-particularly younger, more diverse, and cost-sensitive populations. Despite the affordability and accessibility of OTC devices, traditional hearing aids remain the preferred choice among individuals with more severe hearing loss and those seeking professional support. The report highlights key differences in service delivery, satisfaction, and repurchase intentions between user groups, underscoring the enduring value of professional care. Additionally, the emergence of hearing improvement features in consumer electronics, such as earbuds, signals a broadening of the hearing device landscape. These insights have significant implications for clinical practice, marketing strategies, and policy development, emphasizing the need for flexible, patient-centered care models that accommodate diverse consumer pathways and preferences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.